Investigation Overview
Investigations on behalf of current investors of Noven Pharmaceuticals, Inc (Public, NASDAQ:NOVN) over potential breaches of fiduciary duty and other violations of state law in connection with an alleged unfair takeover price were announced. The investigation by a law firm focuses on potential breaches of fiduciary duty and other violations of state law by the Board of Directors of ...
You must register (for free) or login to view the entire investigation.